Top Stocks for a $500 Investment Now

Given their solid underlying businesses and healthy growth prospects, I am bullish on these two Canadian stocks.

| More on:
Various Canadian dollars in gray pants pocket

Image source: Getty Images

Earlier this week, the United States Labor Department announced that the Consumer Price Index rose 0.3% in April, lower than analysts’ expectation of 0.4%. Year over year, the inflation stood at 3.4%, which aligned with expectations. Investors hope the signs of easing inflation could prompt the United States Federal Reserve to slash interest rates sooner than expected. Amid improving investors’ sentiments, here are two top Canadian stocks that you should look to add to your portfolio

WELL Health Technologies

WELL Health Technologies (TSX:WELL) is one of the top growth stocks to have in your portfolio due to its expanding addressable market and improving profitability. The growing popularity of virtual healthcare services and the digitization of clinical procedures have created a multi-year growth potential for the company. Meanwhile, the company reported an excellent first-quarter performance last week, with its revenue growing by 37%. Organic growth contributed 13%, while the remaining from the acquisitions over the previous four quarters.

With WELL Health focusing on improving its profitability and capital efficiency, its net income stood at $19.6 million compared to a loss of $10.6 million in the previous year’s quarter. However, removing special items, its adjusted net income grew 43.3% year over year to $20.2 million. Also, its free cash flows to shareholders per share increased by 11%.

Further, the company’s investment in developing AI (artificial intelligence)-powered products and continued acquisitions could expand its market share, thus driving its financials in the coming quarters. For 2024, the company’s management expects its revenue to be between $960 million and $980 million, with the midpoint representing a 25% year-over-year increase. Its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) could be in the range of $125 million to $130 million, an improvement from $113.4 million in the previous year.

Despite its healthy outlook, WELL Health trades at 12.7 times analysts’ projected earnings for the next four quarters, making it an attractive buy.

Dollarama

Second on my list is Dollarama (TSX:DOL), a defensive stock with a tilt toward growth. The Canadian discount retailer has an extensive presence nationwide, with 1,551 stores. It has adopted a superior direct-sourcing model, increasing its bargaining power and lowering intermediatory expenses. So, the company can provide a wide range of consumer products at attractive prices. Its attractive pricing has prompted healthy footfalls even during challenging macro environments.

Since fiscal 2011, Dolalrama has grown its sales at an annualized rate of 11.5%. Solid same-store sales and the expansion of its store network from 652 to 1,551 have driven its top line. Along with top-line growth, its adjusted EBITDA has grown at an annualized rate of 17.3%, while its adjusted EBITDA margin has expanded from 16.5% to 31.7%. Supported by these solid financials, the company has returned around 1,315% at an annualized rate of 24.7% over the last 12 years.

Meanwhile, Dollarama has planned to increase its store count to 2,000 by fiscal 2031, while its subsidiary, Dollarcity, expects to add 328 stores over the next five years. Given its capital-efficient, growth-oriented business model, quick sales ramp-up, and low average payback period for new stores, these expansions could continue to drive its financials. The company has also raised its dividends 13 times since 2011. Considering all these factors, I believe Dollarama would be an excellent buy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Investing

High-Yield Heavyweight: 1 REIT That Packs a Punch

SmartCentres REIT (TSX:SRU.UN) is a yield king with a long-term growth plan that could benefit from much lower rates!

Read more »

Where to Invest?
Investing

Yes, You Should Buy U.S. Stocks!

I strongly believe that every Canadian investor should overweight U.S. stocks. Here's why.

Read more »

Dice engraved with the words buy and sell
Bank Stocks

TD Bank Stock: Buy, Sell, or Hold Now?

TD is out of favour with bank investors. Is this a contrarian opportunity?

Read more »

A close up image of Canadian $20 Dollar bills
Dividend Stocks

How Much to Invest to Get $500 in Dividends Every Month

Are you looking for dividends each and every month? This stock is the right "choice" for you, providing stable passive…

Read more »

HIGH VOLTAGE ELECRICITY TOWERS
Dividend Stocks

Dividend Investors: Top Canadian Utility Stocks For June

Here are three of the top Canadian utilities stocks long-term investors may want to consider as portfolio staples moving forward.

Read more »

data analyze research
Dividend Stocks

2 Dividend Stocks to Double Up on Right Now

Two stocks paying monthly dividends are excellent options for income-focused investors looking to increase their passive-income streams.

Read more »

A close up image of Canadian $20 Dollar bills
Dividend Stocks

Invest $7,000 in This Dividend Stock for $519 in Passive Income

A $7,000 investment in this top dividend stock could generate over $519 annually in passive income.

Read more »

Group of people network together with connected devices
Tech Stocks

3 Canadian AI Stocks That Are Minting Coin in 2024

AI stocks like Kinaxis Inc (TSX:KXS) are outperforming the TSX.

Read more »